User profiles for Gerard J. Marek
Gerard MarekGilgamesh Pharmaceuticals Verified email at gilgameshpharmaceutical.com Cited by 9723 |
[HTML][HTML] Serotonin model of schizophrenia: emerging role of glutamate mechanisms
GK Aghajanian, GJ Marek - Brain research reviews, 2000 - Elsevier
The serotonin (5-HT) hypothesis of schizophrenia arose from early studies on interactions
between the hallucinogenic drug LSD (d-lysergic acid diethylamide) and 5-HT in peripheral …
between the hallucinogenic drug LSD (d-lysergic acid diethylamide) and 5-HT in peripheral …
5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex
The influence of 5-HT receptor agonists on the expression of BDNF in brain was determined.
Administration of a hallucinogenic 5-HT 2A /2C receptor agonist, but not a 5-HT 1A receptor …
Administration of a hallucinogenic 5-HT 2A /2C receptor agonist, but not a 5-HT 1A receptor …
[HTML][HTML] Serotonin and hallucinogens
GK Aghajanian, GJ Marek - Neuropsychopharmacology, 1999 - Elsevier
This brief review traces the serotonin (5-HT) hypothesis of the action of hallucinogenic
drugs from the early 1950s to the present day. There is now converging evidence from …
drugs from the early 1950s to the present day. There is now converging evidence from …
[HTML][HTML] Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release
GK Aghajanian, GJ Marek - Brain research, 1999 - Elsevier
Previously, serotonin (5-HT) was found to induce a marked increase in glutamatergic spontaneous
excitatory postsynaptic currents (EPSCs) in apical dendrites of layer V pyramidal cells …
excitatory postsynaptic currents (EPSCs) in apical dendrites of layer V pyramidal cells …
Physiological antagonism between 5-hydroxytryptamine2A and group II metabotropic glutamate receptors in prefrontal cortex
In prefrontal cortex, 5-hydroxytryptamine 2A (5-HT 2A ) receptors have been linked to the
action of hallucinogens and atypical antidepressant/antipsychotic drugs. Previously, we have …
action of hallucinogens and atypical antidepressant/antipsychotic drugs. Previously, we have …
[HTML][HTML] Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders
GJ Marek, LL Carpenter, CJ McDougle… - …, 2003 - nature.com
Recently, the addition of drugs with prominent 5-HT 2 receptor antagonist properties (risperidone,
olanzapine, mirtazapine, and mianserin) to selective serotonin reuptake inhibitors (…
olanzapine, mirtazapine, and mianserin) to selective serotonin reuptake inhibitors (…
[HTML][HTML] 5-HT2A receptor or α1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex
GJ Marek, GK Aghajanian - European journal of pharmacology, 1999 - Elsevier
We compared 5-hydroxytryptamine (5-HT), norepinephrine and dopamine for their efficacy
at increasing excitatory postsynaptic current frequency in layer V pyramidal cells from rat …
at increasing excitatory postsynaptic current frequency in layer V pyramidal cells from rat …
[HTML][HTML] Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors
JC Gewirtz, GJ Marek - Neuropsychopharmacology, 2000 - Elsevier
Recent electrophysiological studies in our laboratory have demonstrated a physiological
interaction between 5-HT 2A and metabotropic glutamate2/3 (mGlu2/3) receptors in the medial …
interaction between 5-HT 2A and metabotropic glutamate2/3 (mGlu2/3) receptors in the medial …
LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
GJ Marek, GK Aghajanian - Journal of Pharmacology and Experimental …, 1996 - ASPET
Correlations between 5-hydroxytryptamine (5-HT) receptor binding affinities and human
hallucinogenic potency have suggested that 5-HT2 receptors mediate the hallucinogenic effects …
hallucinogenic potency have suggested that 5-HT2 receptors mediate the hallucinogenic effects …
Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?
GJ Marek, B Behl, AY Bespalov, G Gross, Y Lee… - Molecular …, 2010 - ASPET
Dopamine D2 receptor blockade has been an obligate mechanism of action present in all
medications that effectively treat positive symptoms of schizophrenia (eg, delusions and …
medications that effectively treat positive symptoms of schizophrenia (eg, delusions and …